Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. MU
6. DFTX
7. APGE
8. LLY
9. RGNX
10. LCO

Go back to Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
Asianada, Inc. (NASDAQ: ASND) Delayed: 232.61 +1.78 (0.77%)
Previous Close $230.83    52 Week High $21.79 
Open $233.00    52 Week Low $11.92 
Day High $236.90    P/E N/A 
Day Low $230.05    EPS $-0.07 
Volume 198,250